Vertex Pharmaceuticals Incorporated
(NASDAQ:VRTX)|
31.77 +0.25 (0.79%) Jan 08 - Close |
|
|
|
Pre-Market 33.49 +1.72 (5.41%) Fri, 9 Jan 2009 7:20 AM
- Compare VRTX with:
- View: Line | Candlestick
Company Profile
Vertex Pharmaceuticals Incorporated
130 Waverly Street
Cambridge, MA 02139-4242
United States - Map
Phone: (617) 444-6100
Fax: (617) 444-6680
Website: www.vpharm.com
State of incorporation: Massachusetts
CEO: Dr. Joshua S. Boger, Ph.D.
Employees: 1,132
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Engaged in structure-based rational drug design
The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.
Recent news for VRTX
-
2009: Positive Outlook for Biotech
Seeking Alpha - Yesterday at 6:32 ET
-
Big Biotechs Loom Large Among Nasdaq's 2008 Winners
Indie Research - Jan 07 at 9:33 ET
-
Business Wire - Jan 06 at 9:15 ET
-
Biotech proves defensive against tough 2008 market
AP - Dec 31 2008 at 7:15 ET
-
Biotech proves defensive against tough 2008 market
AP - Dec 31 2008 at 9:23 ET
-
Pharma Stocks Buck the Market Trend
Seeking Alpha - Dec 29 2008 at 4:20 ET
-
Biopharma Stock Bucks Trend, Beats Market
CNBC - Dec 29 2008 at 12:46 ET
-
Motley Fool - Dec 24 2008 at 8:37 ET
-
Can Vertex Really Charge $75,000 for New Hepatitis C Drug?
Seeking Alpha - Dec 22 2008 at 9:47 ET
-
Vertex Needs A Relaxation Shot
Investopedia - Dec 19 2008 at 4:42 ET
Member sentiment (?) Neutral
Top members owning VRTX
-
Top 4%
+2.40%
-
Top 54%
+1.10%
-
New
+3.41%
* Average monthly return vs. S&P 500